Ö. F. Ölmez Et Al. , "Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?," World Conferance of Lung Cancer:Conquering Thoracic Cancers Worldwide , Barcelona, Spain, pp.551-552, 2019
Ölmez, Ö. F. Et Al. 2019. Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?. World Conferance of Lung Cancer:Conquering Thoracic Cancers Worldwide , (Barcelona, Spain), 551-552.
Ölmez, Ö. F., Bilici, A., Gürsoy, P., Çubukçu, E., Yıldız, O., Sakin, A., ... Korkmaz, T.(2019). Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC? . World Conferance of Lung Cancer:Conquering Thoracic Cancers Worldwide (pp.551-552). Barcelona, Spain
Ölmez, Ömer Et Al. "Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?," World Conferance of Lung Cancer:Conquering Thoracic Cancers Worldwide, Barcelona, Spain, 2019
Ölmez, Ömer F. Et Al. "Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?." World Conferance of Lung Cancer:Conquering Thoracic Cancers Worldwide , Barcelona, Spain, pp.551-552, 2019
Ölmez, Ö. F. Et Al. (2019) . "Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?." World Conferance of Lung Cancer:Conquering Thoracic Cancers Worldwide , Barcelona, Spain, pp.551-552.
@conferencepaper{conferencepaper, author={Ömer Fatih Ölmez Et Al. }, title={Are Pretreatment Inflammation-Based Prognostic Scores Useful in Predicting the Outcomes of Patients with ALK-Positive NSCLC?}, congress name={World Conferance of Lung Cancer:Conquering Thoracic Cancers Worldwide}, city={Barcelona}, country={Spain}, year={2019}, pages={551-552} }